Literature DB >> 29678126

Associations of depression, anxiety and PTSD with neurological disability and cognitive impairment in survivors of moyamoya disease.

Chanchan Liu1, Xiyan Yi2, Ting Li3, Lei Xu4, Mei Hu4, Suming Zhang5, Rifeng Jiang6.   

Abstract

Depression, anxiety and posttraumatic stress disorder (PTSD) are common complications of cerebrovascular diseases. However, they were seldom explored in Moyamoya Disease (MMD) survivors. In this study, we measured the prevalence of depression, anxiety and PTSD in MMD survivors. We evaluated the association of mental disorders with neurological disability and cognitive impairment, and further find out the independent protective and risk factors of neurological disability and cognitive impairment. In MMD survivors, the prevalence of these three mental disorders is high, 46.7% for depression, 50% for anxiety and 47.5% for PTSD. Anxiety and PTSD were significantly associated with more severe neurological disability (p = 0.039 and < 0.001); depression and anxiety were significantly associated with greater cognitive deficiency (p = 0.004 and 0.002). We further found PTSD was the only risk factor associated with neurological disability, and the corresponding odds ratio (OR) and 95% confidence interval (CI) was 81.74 (9.91-674.17); depression and anxiety were risk factors associated with cognitive impairment, and the corresponding OR and 95%CI were 2.73 (1.10-6.81) and 3.37 (1.29-8.78). Therefore, these three mental disorders were associated with more severe neurological disability and greater cognitive deficiency in MMD survivors.

Entities:  

Keywords:  MMSE; Moyamoya disease; depression; modified Rankin score; post-traumatic stress disorder

Mesh:

Year:  2018        PMID: 29678126     DOI: 10.1080/13548506.2018.1467024

Source DB:  PubMed          Journal:  Psychol Health Med        ISSN: 1354-8506            Impact factor:   2.423


  6 in total

1.  Relationship between NIH stroke symptoms and post-traumatic stress disorder in patients evaluated for transient ischemic attack/stroke.

Authors:  Emily Pedowitz; Lilly Derby; Gaspar J Cruz; Alison Trainor; Donald Edmondson; Talea Cornelius
Journal:  Gen Hosp Psychiatry       Date:  2021-03-08       Impact factor: 3.238

2.  Mood and Stress Evaluation of Adult Patients With Moyamoya Disease in Korea: Ecological Momentary Assessment Method Using a Mobile Phone App.

Authors:  Kyu Won Shim; Mona Choi; Yong Sook Yang; Gi Wook Ryu; Chang Gi Park; Insun Yeom
Journal:  JMIR Mhealth Uhealth       Date:  2020-05-25       Impact factor: 4.773

3.  Psychometric Properties of the Korean Version of the PsyMate Scale Using a Smartphone App: Ecological Momentary Assessment Study.

Authors:  Yong Sook Yang; Gi Wook Ryu; Philippe A E G Delespaul; Mona Choi
Journal:  JMIR Mhealth Uhealth       Date:  2020-07-21       Impact factor: 4.773

4.  The effects of COVID-19 continuous traumatic stressors on mental health and cognitive functioning: A case example from Turkey.

Authors:  Ibrahim A Kira; Emre Han Alpay; Yunus Emre Ayna; Hanaa A M Shuwiekh; Jeffrey S Ashby; Aras Turkeli
Journal:  Curr Psychol       Date:  2021-04-21

5.  Clinical Characteristics and Long-Term Outcome of Headaches Associated With Moyamoya Disease in the Chinese Population-A Cohort Study.

Authors:  Bin Gao; Kaijiang Kang; Jia Zhang; Dong Zhang; Xingquan Zhao
Journal:  Front Neurol       Date:  2020-11-26       Impact factor: 4.003

6.  Predicting Decreased Activities of Daily Living in Patients with Moyamoya Disease after Revascularization: Development and Assessment of a New Predictive Nomogram.

Authors:  Yani Zhao; Dongliang Yang; Gang Li; Peng Zhao; Xiaorong Luan; Haiyan Li
Journal:  Biomed Res Int       Date:  2021-04-05       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.